相关产品推荐更多 >

Influenza A H1N2 (A/swine/Papenburg/IDT12653/2010) Neuraminidase / NA (His Tag)
¥5170
重组甲型流感 H1N1 Hemagglutinin/HA蛋白(Y108F, His & AVI Tag)
¥3220
Influenza A H1N1 (A/AA/Huston/1945) Hemagglutinin / HA Protein (His Tag)
¥4520
重组新冠病毒 (LP.8.1) Coronavirus spike蛋白
¥4500
Influenza A H1N2 (A/Swine/Indiana/P12439/00) Neuraminidase / NA (His Tag)
¥5170
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-20℃ to -80℃
- 保质期:
12个月
- 英文名:
Influenza A H3N2 (A/Cambodia/e0826360/2020) Neuraminidase / NA Protein (His Tag)
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 规格:
100 µg
蛋白名称:Influenza A H3N2 (A/Cambodia/e0826360/2020) NA重组蛋白
蛋白构建:A DNA sequence encoding the Influenza A virus (A/Cambodia/e0826360/2020 (H3N2)) neuraminidase (translated amino acids of EPI1837752) (Ile30-Ile469) was expressed with a vasodilator-stimulated phosphoprotein tetramerization domain at the N-terminus and a polyhistidine tag at the C-terminus.
表达宿主:Baculovirus-Insect Cells
蛋白纯度:> 95 % as determined by SDS-PAGE.
蛋白活性:见说明书
蛋白内毒素:< 1.0 EU per μg protein as determined by the LAL method.
预测N端:Asp
蛋白分子量:The recombinant Influenza A virus (A/Cambodia/e0826360/2020 (H3N2)) NA consists of 486 amino acids and predicts a molecular mass of 54.7 kDa. It migrates as an approximately 66.9 kDa band in SDS-PAGE under reducing conditions.
蛋白NP号:EPI1837752
蛋白氨基酸序列:Ile30-Ile469
蛋白标签:C-His
蛋白保存条件:Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Neuraminidase inhibitors (NAIs) are presently the only effective antiviral drugs for treatment and chemoprophylaxis of influenza A and B infections, due to the high prevalence of resistance to the adamantane class of drugs among influenza
PCR for the Detection of Influenza Viruses in Clinical Material
). Influenza A viruses are further divided into subtypes H1N1, H2N2 and H3N2, based on differences in the hemagglutinin (HA) and neuraminidase (NA) genes. The ability of influenza viruses to undergo antigenic change in HA and NA enables the virus to evade
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
技术资料暂无技术资料 索取技术资料




